Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Respiratory Medicine|September 10, 2023
Long-term clinical outcomes of elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis and advanced pulmonary diseaseDaniela Savi, Francesca Lucca, Gloria Tridello, et al.International Journal of Molecular Sciences|November 13, 2025
Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort StudySonia Volpi, Maura Ambroni, Roberto Buzzetti, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 27, 2010
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary diseasePatrizia Risé, Sonia Volpi, Claudio Colombo, et al.The Journal of Clinical Endocrinology and Metabolism|December 17, 2020
Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell FunctionClaudia Piona, Sonia Volpi, Chiara Zusi, et al.The Journal of Clinical Endocrinology and Metabolism|July 12, 2024
A Longitudinal Study of Glucose Tolerance in Cystic Fibrosis: The Central Role of Beta Cell Functional MassClaudia Piona, Enza Mozzillo, Antonella Tosco, et al.Chest|March 23, 2024
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung DiseaseAndrea Gramegna, Gianfranco Alicandro, Chiara Premuda, et al.Journal of Clinical Medicine|July 27, 2022
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic FibrosisClaudia Piona, Enza Mozzillo, Antonella Tosco, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 19, 2023
The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective studyElton Dajti, Federico Ravaioli, Giulia Paiola, et al.Pediatrics|May 13, 2015
Inconclusive diagnosis of cystic fibrosis after newborn screeningChee Y Ooi, Carlo Castellani, Katherine Keenan, et al.Nature Communications|January 10, 2023
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulationValentino Bezzerri, Valentina Gentili, Martina Api, et al.Pageof 3